methazolamide has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Zhu, S | 1 |
| Pei, Z | 1 |
| Drozda, M | 1 |
| Stavrovskaya, IG | 1 |
| Del Signore, SJ | 1 |
| Cormier, K | 1 |
| Shimony, EM | 1 |
| Wang, H | 1 |
| Ferrante, RJ | 1 |
| Kristal, BS | 1 |
| Friedlander, RM | 1 |
1 other study available for methazolamide and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease.
Topics: Animals; Brain; Carbonic Anhydrase Inhibitors; Caspases; Cell Death; Cell Line, Transformed; Cytochr | 2008 |